Medirom Healthcare Technologies (MRM) Current Deferred Revenue (2019 - 2024)
Medirom Healthcare Technologies has reported Current Deferred Revenue over the past 6 years, most recently at $351812.3 for Q4 2024.
- Quarterly results put Current Deferred Revenue at $351812.3 for Q4 2024, down 52.42% from a year ago — trailing twelve months through Dec 2024 was $351812.3 (down 52.42% YoY), and the annual figure for FY2024 was $351812.3, down 52.42%.
- Current Deferred Revenue for Q4 2024 was $351812.3 at Medirom Healthcare Technologies, down from $739487.3 in the prior quarter.
- Over the last five years, Current Deferred Revenue for MRM hit a ceiling of $1.6 million in Q4 2020 and a floor of $351812.3 in Q4 2024.
- Median Current Deferred Revenue over the past 5 years was $739487.3 (2023), compared with a mean of $856899.1.
- Biggest five-year swings in Current Deferred Revenue: increased 17.37% in 2023 and later tumbled 52.42% in 2024.
- Medirom Healthcare Technologies' Current Deferred Revenue stood at $1.6 million in 2020, then plummeted by 44.34% to $916515.8 in 2021, then crashed by 31.26% to $630027.0 in 2022, then rose by 17.37% to $739487.3 in 2023, then tumbled by 52.42% to $351812.3 in 2024.
- The last three reported values for Current Deferred Revenue were $351812.3 (Q4 2024), $739487.3 (Q4 2023), and $630027.0 (Q4 2022) per Business Quant data.